Results pending
Riluzole: protect nerve tissue in early MS (CIS or RIS)
early MS (CIS or RIS) · Axonal protection / ion channels / excitotoxicity
Trials have finished, but some results have not been read yet. There is no verdict until they are, because one unread trial can change the answer.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 43
Human genetics
Genes linked to MS that these medicines act on: SCN3A
How the verdict was reached
Phase 2 results not all read yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Interferon beta-1a, phase 2 | Phase 2 | 43 | 2006 | No results found Paper abstract | Will count once its result is read |
Counted: 0. Will count later: 1. Not counted: 0.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Results pending
Related hypotheses
Assembled by software from public sources.